Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03375216 · ClinicalTrials.gov registry record · NA
Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering
A NA study of Sensory Deficit and Analgesic Drug Dependence, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03375216 is a NA study of Sensory Deficit and Analgesic Drug Dependence that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03375216, a NA study of Sensory Deficit and Analgesic Drug Dependence, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Few studies have used quantitative sensory tests to study the effect of chronic opioid treatment on sensation. The investigators will test chronic pain patients who are on different MEDDs, normal volunteers, and patients undergoing an opioid taper. This will be the first study to perform sensory testing on patients while undergoing an opioid taper on an outpatient basis.
Conditions Studied
Interventions
- BEHAVIORAL sensory testing (Heat, cold, and pressure)
- BEHAVIORAL Promis Survey
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2023-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03375216
The ClinicalTrials.gov registry entry for NCT03375216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sensory Deficit appearing as the primary indexed condition, and to 2 interventions - of which sensory testing (Heat, cold, and pressure) is the first listed.
NCT03375216 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03375216 about?
NCT03375216 is a clinical study titled "Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering". Few studies have used quantitative sensory tests to study the effect of chronic opioid treatment on sensation. The investigators will test chronic pain patients who are on different MEDDs, normal volunteers, and patients undergoing an opioid taper. This will be the first study to perform sensory tes...
What is the current status of trial NCT03375216?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-12-22. Estimated completion is 2023-11-18.
What conditions does trial NCT03375216 study?
This clinical trial studies the following conditions: Sensory Deficit, Analgesic Drug Dependence.
What interventions are being tested in trial NCT03375216?
The interventions under investigation include: sensory testing (Heat, cold, and pressure) (BEHAVIORAL), Promis Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT03375216?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03375216 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensory Deficit
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.